Track topics on Twitter Track topics that are important to you
Hanson & Doremus Investment Management lowered its stake in shares of Teva Pharmaceutical Industries Ltd. by 2.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission . The firm owned 27,416 shares of the company's stock after selling 565 shares during the period.
Original Article: Hanson & Doremus Investment Management Decreases Position in...NEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...